Status:
COMPLETED
Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes (MK-0000-113)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
41+ years
Brief Summary
The purpose of this study is to evaluate the degree of beta-cell dysfunction among participants with type 2 diabetes and the association between beta-cell dysfunction and demographic, clinical, and tr...
Eligibility Criteria
Inclusion
- Physician diagnosis of type 2 diabetes mellitus by American Diabetes Association (ADA) criteria
- Oral hypoglycemic drug therapy for ≥1 year
- Continuous care at the clinic (at least 2 visits) for at least one year
- Medical records completed with a minimum core data set
- Completed consent form
Exclusion
- Participation in a clinical trial in the previous 1 year
- Currently using insulin
- Type 1 diabetes
- Pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
507 Patients enrolled
Trial Details
Trial ID
NCT01472341
Start Date
November 1 2008
End Date
December 1 2013
Last Update
March 10 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.